SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc. (ASX: EBR), developer of the world’s only leadless left ventricular endocardial pacing (LVEP) system for heart failure, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has initiated a National Coverage Determination (NCD) to evaluate uniform Medicare coverage for leadless LV endocardial pacing used in cardiac resynchronization therapy (CRT). The initiation of the NCD process is a key outcome of EBR’s engageme
See full post here as originally published on this site
